Ethiopia study maps genetic factors affecting HIV drug dosing in children

Researchers identified genetic and non-genetic factors that influence how children's bodies process efavirenz, a common HIV medication. The findings could help clinicians optimize drug doses for African pediatric patients, potentially improving treatment outcomes while reducing side effects in a population with limited access to alternative therapies.

Originaltitel: Genetic and non-genetic factors influencing efavirenz population pharmacokinetics among human immunodeficiency virus-1-infected children in Ethiopia